Mirror-image device exercise for arm weakness after stroke
Tests a mirror-image device added to usual therapy in stroke patients.
Key facts
- Who runs it
- Clinique Les Trois Soleils
- Where
- Boissise-le-Roi, Cosne-Cours-sur-Loire, Reims, Saint-Paul-lès-Dax, and Villiers-sur-Orge, FranceSee the 5 sites
- Trial code
- Registry title
- Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
- Status
- Recruiting
- People taking part
- 66 people, planned
- Started
- 10 Dec 2019
- Expected to end
- 31 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Conventional rehabilitation
- Intensive Visual Simulation
- Record updated
- 18 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a stroke 4 to 10 weeks ago and have weakness on one side, with poor wrist and hand movement.
- Age
- 18 to 100 years
- Sex
- All sexes can join.
- Disease stage
- Weakness on one side of the body after a stroke caused by one focal brain lesion. The stroke happened 4 to 10 weeks before the start. Wrist and hand sub-scores of the Fugl-Meyer total less than 16.
- Earlier treatment
- People who had mirror therapy or IVS rehabilitation before joining cannot join.
Main reasons for not taking part
- Memory or thinking problems or a worsening illness that makes taking part impossible
- Speech or language problems that prevent understanding instructions
- Taking part in another clinical trial
- Neurological conditions before the stroke
- Rheumatological disease of the hand and wrist
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥18 years
- Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline
- Total sub-scores wrist and hand of th Fugl-Meyer < 16
- Patient having agreed to sign an informed consent
- patient being affiliated to the French Social Security
Who cannot take part
- Neurological conditions prior to stroke
- Patient who had mirror therapy or IVS rehabilitation before inclusion
- Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
- Phasic disorders that prevent the understanding of instructions
- Patient include in an other clinical trial
- Rheumatological pathology of the hand and wrist
- Person under legal protection measure
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in France
- Clinique Les Trois SoleilsBoissise-le-Roi, FranceContact: Christophe Duret, MDTaking people
- CRF PasoriCosne-Cours-sur-Loire, FranceContact: Nikolay Dobrev, MDTaking people
- CHU SébastopolReims, FranceContact: François BOYER, PhDNot yet recruiting
- Clinique NapoléonSaint-Paul-lès-Dax, FranceContact: Magali CAPLANNE, MDNot yet recruiting
- Clinalliance Villiers-sur OrgeVilliers-sur-Orge, FranceContact: Manuel Wiese, MDTaking people
About the trial
What the trial wants to find out
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb.
Read full original descriptionShow less
The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm.
The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation.
Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
The 2 groups in the trial
- Conventional RehabilitationExisting treatment, for comparison
at least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.
- Intensive Visual SimulationTreatment being tested
at least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.
Treatment: Conventional rehabilitation and Intensive Visual Simulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Intensive Rehabilitation Program With Intensive Visual Numerical Simulation Device for Improving Distal Motor Performance and Upper Limb Functional Capacity in Subacute Hemiparetics After Stroke. Randomized Controlled Trial.
- Plain-language title
- Mirror-image device exercise for arm weakness after strokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04119544, who can take part
- Record updated
- 18 March 2026